Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Villanueva Rodriguez AlfonsoEVP and Group CEO-VZ Consumer |  VZVERIZON COMMUNICATIONS INCGrant or award | A | $1,738 135 sh |
| Oct 23, 2026 traded Oct 22, 2026 |
| 9 | Dobson David CDirector |  WLYWLYBJOHN WILEY & SONS, INC.Grant or award | A | $12K 228 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 9 | Blackburn KellyEVP, Clinical Development |  CRVOCervoMed Inc.Grant or award | A | — 19.1K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 9 | De Rosch MarkEVP, RA and GA and PgM | CRVOCervoMed Inc. Grant or award | A | — 19.1K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 9 | Winton MatthewChief Commercial and Business | CRVOCervoMed Inc. Grant or award | A | — 19.1K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 9 | Valli Todd A.Chief Accounting Officer |  FIRYFiry Inc.Grant or award | A | — 10.7K sh | Oct 23, 2026 traded Oct 23, 2026 |
| 9 | Maloney Michael StephenDirector |  BMNRBITMINE IMMERSION TECHNOLOGIES, INC.Option exercise | M | — 3,999 sh | Oct 23, 2026 traded Oct 23, 2026 |
| 9 | Garner John B.Head of Strategy and Vision |  WSHPWeShop Holdings LtdOption exercise | M | — 18.5K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 9 | Madden Karen NDirector | WLYWLYBJOHN WILEY & SONS, INC. Grant or award | A | $2,972 55 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 9 | Pershing EdwardDirector, CEO, 10% Owner |  PVCTPROVECTUS BIOPHARMACEUTICALS, INC.Option exercise | M | — 7,599 sh | Oct 23, 2026 traded Oct 23, 2026 |
| 9 | Andresen Katherine DunnDirector | WLYWLYBJOHN WILEY & SONS, INC. Grant or award | A | $2,540 47 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 9 | Stillwell Mary-LeeSVP and Controller | VZVERIZON COMMUNICATIONS INC Grant or award | A | $585 45 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 8 | Borgeson John A.Chief Financial Officer |  KODKodiak Sciences Inc.Open-market sale · 10b5-1 plan | SELL | $185K 2,000 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $46K 194 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $29K 120 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $18K 80 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Gheuens SarahChief Medical Officer |  AGIOAGIOS PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $56K 1,489 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Borgeson John A.Chief Financial Officer | KODKodiak Sciences Inc. Open-market sale · 10b5-1 plan | SELL | $150K 1,677 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Borgeson John A.Chief Financial Officer | KODKodiak Sciences Inc. Open-market sale · 10b5-1 plan | SELL | $187K 2,000 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Pershing EdwardDirector, CEO, 10% Owner | PVCTPROVECTUS BIOPHARMACEUTICALS, INC. Option exercise | M | — | Oct 23, 2026 traded Oct 23, 2026 |
| 6 | Borgeson John A.Chief Financial Officer | KODKodiak Sciences Inc. Option exercise · 10b5-1 plan | M | $75K 30.0K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 6 | Honeycutt JenniferDirector, President and CEO |  VLTOVeralto CorpOption exercise · 10b5-1 plan | M | $204K 7,098 sh | Oct 23, 2026 traded Oct 23, 2026 |
| 5 | rahim ramiEVP, Pres GM Networking |  HPEHewlett Packard Enterprise CoGrant or award · 10b5-1 plan | A | — 252 sh | Oct 23, 2026 traded Oct 16, 2026 |
| 5 | rahim ramiEVP, Pres GM Networking | HPEHewlett Packard Enterprise Co Grant or award · 10b5-1 plan | A | — 579 sh | Oct 23, 2026 traded Oct 16, 2026 |
| 5 | Borgeson John A.Chief Financial Officer | KODKodiak Sciences Inc. Open-market sale · 10b5-1 plan | SELL | $9,491 100 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 5 | Lentz DanielCFO & COO |  CMRCCommerce.com, Inc.Tax withholding | F | $6,241 1,724 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Sarowitz Steven IDirector, 10% Owner |  PCTYPaylocity Holding CorpOpen-market sale · 10b5-1 plan | SELL | $267K 1,564 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Sarowitz Steven IDirector, 10% Owner | PCTYPaylocity Holding Corp Open-market sale · 10b5-1 plan | SELL | $463K 2,728 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Rogers Daniel MarkDirector, Chief Executive Officer |  ASANAsana, Inc.Open-market sale · 10b5-1 plan | SELL | $227K 19.7K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 4 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner |  PUBMPubMatic, Inc.Option exercise · 10b5-1 plan | M | — 21.9K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 4 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | PUBMPubMatic, Inc. Derivative conversion · 10b5-1 plan | C | — 34.4K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner |  CRCTCricut, Inc.Open-market sale · 10b5-1 plan | SELL | $376K 60.0K sh | Oct 23, 2026 traded Oct 23, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | CRCTCricut, Inc. Open-market sale · 10b5-1 plan | SELL | $379K 60.0K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | CRCTCricut, Inc. Open-market sale · 10b5-1 plan | SELL | $379K 60.0K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner |  IBTAIbotta, Inc.Option exercise · 10b5-1 plan | M | — 15.3K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 3 | Borgeson John A.Chief Financial Officer | KODKodiak Sciences Inc. Option exercise · 10b5-1 plan | M | — 30.0K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 3 | Gheuens SarahChief Medical Officer | AGIOAGIOS PHARMACEUTICALS, INC. Option exercise · 10b5-1 plan | M | — 1,489 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 2 | Malady KyleEVP and Group CEO-VZ Business | VZVERIZON COMMUNICATIONS INC Grant or award | A | $1,738 135 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 1 | Gheuens SarahChief Medical Officer | AGIOAGIOS PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $19K 500 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 1 | Sarowitz Steven IDirector, 10% Owner | PCTYPaylocity Holding Corp Open-market sale · 10b5-1 plan | SELL | $93K 552 sh | Oct 23, 2026 traded Oct 21, 2026 |
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K